Table 5.
Survival
| nTMS | non-nTMS | p-value | ||
|---|---|---|---|---|
| All tumors | Overall survival (months) | 15.7 ± 10.9 | 11.9 ± 10.3 | 0.1310 |
| 3 months survival rate (%) | 93.7 | 80.9 | 0.0298 | |
| 6 months survival rate (%) | 88.5 | 62.7 | 0.0015 | |
| 9 months survival rate (%) | 72.9 | 50.7 | 0.0167 | |
| 12 months survival rate (%) | 58.7 | 40.3 | 0.0544 | |
| WHO grade III | Overall survival (months) | 21.5 ± 9.0 | 7.2 ± 3.6 | 0.0322 |
| 3 months survival rate (%) | 100.0 | 100.0 | 1.000 | |
| 6 months survival rate (%) | 100.0 | 84.6 | 0.1410 | |
| 9 months survival rate (%) | 91.7 | 76.9 | 0.3151 | |
| 12 months survival rate (%) | 80.0 | 69.2 | 0.5598 | |
| WHO grade IV | Overall survival (months) | 15.1 ± 11.1 | 12.4 ± 10.6 | 0.3196 |
| 3 months survival rate (%) | 91.8 | 76.4 | 0.0332 | |
| 6 months survival rate (%) | 84.6 | 57.4 | 0.0052 | |
| 9 months survival rate (%) | 66.7 | 44.4 | 0.0384 | |
| 12 months survival rate (%) | 52.8 | 33.3 | 0.0663 | |
Detailed survival data including mean overall survival, 3, 6, 9, and 12 months survival rates for all tumor patients and separately for WHO grade III and IV tumor patients of both groups.